Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Sufentanil vs IV Fentanyl for Acute Pain
NCT04177862Phase 4Completed
- Sponsor
- University of Minnesota
- Start
- Dec 2019
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sufentanil in acute pain (2 arms), sponsored by University of Minnesota. Primary endpoint: Recovery Room Time at 1 day. Started Dec 2019; status: completed.
02
Drugs
sufentanil
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT04177862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04177862.